COST-EFFECTIVENESS OF ALTEPLASE TO TREAT ACUTE ISCHEMIC STROKE WITHIN 4.5 HOURS AFTER ONSET IN THE BRAZILIAN UNIFIED HEALTH SYSTEM PERSPECTIVE

被引:0
|
作者
Campos, D. B. [1 ]
Martins, S. O. [2 ]
Safanelli, J. [3 ]
Santoni, N. B. [4 ]
Marcolino, M. [5 ]
Antonini Ribeiro, R. [6 ]
机构
[1] Boehringer Ingelheim Brazil, Sao Paulo, Brazil
[2] Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[3] Joinville Stroke Registry, Joinville, Brazil
[4] Boehringer Ingelheim GmbH & Co KG, Sao Paulo, Brazil
[5] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[6] HTAnalyze, Porto Alegre, RS, Brazil
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PND26
引用
收藏
页码:S626 / S627
页数:2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF THROMBOLYSIS WITHIN 4.5 HOURS OF ACUTE ISCHEMIC STROKE IN CHINA
    Pan, Y.
    Wang, Y. L.
    Liu, G.
    Zhao, K.
    Wang, Y.
    VALUE IN HEALTH, 2014, 17 (07) : A725 - A725
  • [2] Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China
    Pan, Yuesong
    Chen, Qidong
    Zhao, Xingquan
    Liao, Xiaoling
    Wang, Chunjuan
    Du, Wanliang
    Liu, Gaifen
    Liu, Liping
    Wang, Chunxue
    Wang, Yilong
    Wang, Yongjun
    PLOS ONE, 2014, 9 (10):
  • [3] Cost-Effectiveness of Thrombolysis Within 4.5 Hours of Acute Ischemic Stroke Experience From Australian Stroke Center
    Tanny, Sharman P. Tan
    Busija, Lucy
    Liew, Danny
    Teo, Sarah
    Davis, Stephen M.
    Yan, Bernard
    STROKE, 2013, 44 (08) : 2269 - 2274
  • [4] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    Hacke, Werner
    Kaste, Markku
    Bluhmki, Erich
    Brozman, Miroslav
    Davalos, Antoni
    Guidetti, Donata
    Larrue, Vincent
    Lees, Kennedy R.
    Medeghri, Zakaria
    Machnig, Thomas
    Schneider, Dietmar
    von Kummer, Ruediger
    Wahlgren, Nils
    Toni, Danilo
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13): : 1317 - 1329
  • [5] A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke
    Boudreau, Denise M.
    Guzauskas, Greg
    Villa, Kathleen F.
    Fagan, Susan C.
    Veenstra, David L.
    ANNALS OF EMERGENCY MEDICINE, 2013, 61 (01) : 46 - 55
  • [6] Thrombolysis with Alteplase 4.5-6 Hours after Acute Ischemic Stroke
    Zhang, Bin
    Sun, Xiao-jiang
    Ju, Chi-heng
    EUROPEAN NEUROLOGY, 2011, 65 (03) : 170 - 174
  • [7] COST-EFFECTIVENESS ANALYSIS OF THROMBOLYSIS WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (ALTEPLASE) FOR ACUTE ISCHEMIC STROKE UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Teich, V
    Passos, R. B. F.
    Vianna, D.
    VALUE IN HEALTH, 2009, 12 (07) : A503 - A503
  • [8] Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
    Nguyen, Chi
    Lahr, Maarten M. H.
    Van Der Zee, Durk Jouke
    Van Voorst, Henk
    Roos, Yvo
    Uyttenboogaart, Maarten
    Buskens, Erik
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP121 - NP122
  • [9] TENECTEPLASE OR ALTEPLASE FOR ACUTE ISCHEMIC STROKE? A COST-EFFECTIVENESS ANALYSIS
    Nguyen, C.
    Lahr, M. M. H.
    Van der Zee, D. J.
    Van Voorst, H.
    Roos, Y. B. W. E. M.
    Uyttenboogaart, M.
    Buskens, E.
    VALUE IN HEALTH, 2022, 25 (12) : S167 - S167
  • [10] Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
    Nguyen, Chi Phuong
    Lahr, Maarten M. H.
    van der Zee, Durk-Jouke
    van Voorst, Henk
    Roos, Yvo B. W. E. M.
    Uyttenboogaart, Maarten
    Buskens, Erik
    CONTRAST Consortium
    EUROPEAN STROKE JOURNAL, 2023, 8 (03) : 638 - 646